Literature DB >> 3906066

Concomitant immunohistochemical localization of fibronectin and collagen in schistosome granulomata.

M S Al Adnani.   

Abstract

Affinity purified antibodies to human collagen type I and III and antihuman fibronectin, were employed immunohistochemically on formalin-fixed, paraffin-embedded human tissue containing schistosome granulomata. The distribution of the three connective tissue proteins was studied in 45 biopsies in which there was Schistosoma haematobium (30) and Schistosoma mansoni (15) infestation. The granulomata were divided into early, intermediate and late according to the proportion of inflammatory cell types and the degree of fibrous tissue deposition. Only fibronectin was detected in the early granuloma where macrophages are the main cell type. In the intermediate granuloma both fibronectin and collagen type III were localized along reticulin positive fibres; spindle cells, (presumptive fibroblasts) and macrophages were the cell types present at this stage. Collagen type I was mainly localized in the late granuloma. Hyalinized connective tissue was negative for the three proteins. The loose connective tissue and walls of blood vessels were constantly stained for fibronectin and collagen type III in normal areas distant from granulomata. These results raise the possibility of using localization of fibronectin and collagen as a means to stage the duration of chronic fibrotic diseases.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3906066     DOI: 10.1002/path.1711470202

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  9 in total

1.  Splendore-Hoeppli phenomenon in bronchocentric granulomatosis.

Authors:  Y Yoshikawa; L D Truong; T Watanabe
Journal:  Thorax       Date:  1988-02       Impact factor: 9.139

2.  The pathogenesis of liver fibrosis in schistosomiasis japonica: sequential qualitative and quantitative immunohistochemical study of extracellular components in schistosomal egg granulomas in murine liver.

Authors:  Y H Xu; Z B Wu
Journal:  J Tongji Med Univ       Date:  1988

Review 3.  Immunopathology of Schistosoma mansoni infection.

Authors:  D L Boros
Journal:  Clin Microbiol Rev       Date:  1989-07       Impact factor: 26.132

4.  Identification of cells responsible for synthesis of sulphated glycosaminoglycans in schistosome-induced hepatic granulomas.

Authors:  L C Silva; R Borojevic; P A Mourão
Journal:  Int J Exp Pathol       Date:  1990-12       Impact factor: 1.925

5.  T-lymphocyte responsiveness in murine schistosomiasis mansoni is dependent upon the adhesion molecules intercellular adhesion molecule-1, lymphocyte function-associated antigen-1, and very late antigen-4.

Authors:  J G Langley; D L Boros
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

6.  Proteomic identification of plasma protein tyrosine phosphatase alpha and fibronectin associated with liver fluke, Opisthorchis viverrini, infection.

Authors:  Jarinya Khoontawad; Umawadee Laothong; Sittiruk Roytrakul; Porntip Pinlaor; Jason Mulvenna; Chaisiri Wongkham; Puangrat Yongvanit; Chawalit Pairojkul; Eimorn Mairiang; Paiboon Sithithaworn; Somchai Pinlaor
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

7.  Serum complement C4b, fibronectin, and prolidase are associated with the pathological changes of pulmonary tuberculosis.

Authors:  Chong Wang; Yan-Yuan Li; Xiang Li; Li-Liang Wei; Xiu-Yun Yang; Dan-Dan Xu; Ting-Ting Jiang; Zhong-Jie Li; Zhong-Liang Chen; Xing Zhang; Ji-Yan Liu; Ze-Peng Ping; Ji-Cheng Li
Journal:  BMC Infect Dis       Date:  2014-01-31       Impact factor: 3.090

Review 8.  Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses.

Authors:  Alice H Costain; Andrew S MacDonald; Hermelijn H Smits
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

Review 9.  Schistosoma "Eggs-Iting" the Host: Granuloma Formation and Egg Excretion.

Authors:  Christian Schwartz; Padraic G Fallon
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.